Literature DB >> 22892613

Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review.

Alauldin Khalef Alhowaish1, Nathalie Dietrich, Meltem Onder, Klaus Fritz.   

Abstract

Vitiligo is a relatively common acquired disorder, characterized by progressive loss of melanocytes from the epidermis and the epidermal appendages. The disease is associated with considerable morbidity because of a major impact on the quality of life. The treatment for vitiligo is generally unsatisfactory and challenging. There are a variety of therapeutic possibilities including topical corticosteroids, topical calcineurin inhibitors, as well as phototherapy with Psoralen plus UVA (PUVA), narrow-band UVB, and a 308-nm excimer laser and/or lamps. Furthermore, surgical methods encompass grafting and transplantation while depigmentation treatments and psychological support may also be considered. The objective is to assess the effect of the 380-nm excimer laser in the treatment of vitiligo based on the available studies and case series. We searched the relevant literature about vitiligo and excimer laser published between 1990 and 2012 using the MEDLINE database. We reviewed all relevant articles about 308-nm excimer laser and light sources assessing their efficacy in the management of vitiligo as well as their side effects. The value of combination treatment methods was also analyzed. The available studies provide strong evidence that the excimer laser represents the most effective approach to treat vitiligo compared to ordinary phototherapy. Excimer laser is relatively safe and effective for localized disease. UV-sensitive areas respond best as well as a short duration of the disease. More frequent treatments achieve better results. Compared to other treatment modalities, the excimer laser most likely constitutes the treatment of choice for localized vitiligo. Its efficacy can be further improved in combination with other therapies such as corticosteroids, pimecrolimus, or tacrolimus.

Entities:  

Mesh:

Year:  2012        PMID: 22892613     DOI: 10.1007/s10103-012-1185-1

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  37 in total

1.  Treatment of vitiligo with the 308-nm excimer laser: a pilot study.

Authors:  James M Spencer; Robert Nossa; Jyotendra Ajmeri
Journal:  J Am Acad Dermatol       Date:  2002-05       Impact factor: 11.527

2.  Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study.

Authors:  Adam Z Kawalek; James M Spencer; Robert G Phelps
Journal:  Dermatol Surg       Date:  2004-02       Impact factor: 3.398

3.  Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo.

Authors:  Xiu-Ying Zhang; Yan-Ling He; Jie Dong; Jun-Zhu Xu; Jie Wang
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-06       Impact factor: 3.135

Review 4.  Photo(chemo)therapy for vitiligo.

Authors:  Alessia Pacifico; Giovanni Leone
Journal:  Photodermatol Photoimmunol Photomed       Date:  2011-10       Impact factor: 3.135

5.  Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo.

Authors:  Yang Hui-Lan; Huang Xiao-Yan; Fan Jian-Yong; Liu Zong-Rong
Journal:  Pediatr Dermatol       Date:  2009 May-Jun       Impact factor: 1.588

6.  [Excimer laser treatment of vitiligo -- critical retrospective assessment of own results and literature overview].

Authors:  Bärbel Greve; Christian Raulin; Edda Fischer
Journal:  J Dtsch Dermatol Ges       Date:  2006-01       Impact factor: 5.584

7.  The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo.

Authors:  Suhyun Cho; Zhenlong Zheng; Yoon-Kee Park; Mi Ryung Roh
Journal:  Photodermatol Photoimmunol Photomed       Date:  2011-02       Impact factor: 3.135

Review 8.  Use of the 308-nm excimer laser for psoriasis and vitiligo.

Authors:  Thierry Passeron; Jean-Paul Ortonne
Journal:  Clin Dermatol       Date:  2006 Jan-Feb       Impact factor: 3.541

9.  Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.

Authors:  Rosita Saraceno; Steven P Nisticò; Elisabetta Capriotti; Sergio Chimenti
Journal:  Dermatol Ther       Date:  2009 Jul-Aug       Impact factor: 2.851

Review 10.  Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review.

Authors:  Electra Nicolaidou; Christina Antoniou; Alexander Stratigos; Andreas D Katsambas
Journal:  J Am Acad Dermatol       Date:  2009-01-20       Impact factor: 11.527

View more
  6 in total

Review 1.  Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.

Authors:  Mark Nestor; Vivian Bucay; Valerie Callender; Joel L Cohen; Neil Sadick; Heidi Waldorf
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

Review 2.  [The 308 nm Excimer laser : Treatment of vitiligo and hypopigmentation].

Authors:  K Fritz; C Salavastru
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 3.  [The 308 nm Excimer laser for the treatment of psoriasis and inflammatory skin diseases].

Authors:  K Fritz; C Salavastru
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

4.  A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo.

Authors:  Silada Kanokrungsee; Kumutnart Chanprapaph; Chayada Chaiyabutr; Vasanop Vachiramon
Journal:  Lasers Med Sci       Date:  2016-06-13       Impact factor: 3.161

5.  Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.

Authors:  M El-Domyati; W H El-Din; A F Rezk; I Chervoneva; J B Lee; M Farber; J Uitto; O Igoucheva; Vitali Alexeev
Journal:  Arch Dermatol Res       Date:  2021-04-17       Impact factor: 3.017

6.  Isolation of a Melanoblast Stimulator from Dimocarpus longan, Its Structural Modification, and Structure-Activity Relationships for Vitiligo.

Authors:  Jae-Won Song; Sunju Choi; Gayeong Kim; Hyang Bok Lee; P Sankara Rao; Jeonghyun Shin; Eun Ki Kim; Dong-Gyu Cho
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.